Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier

Plastic and Reconstructive Surgery

Volumn 98, Issue 2, 1996, Pages 247-259

  Mayer, Michael ^b   Hollinger, Jeffrey ^a   Ron, Eyal ^b   Wozney, John ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GRAFT; BONE REGENERATION; CLEFT PALATE; DOG; NONHUMAN; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ALVEOLAR PROCESS; ANIMALS; BLOOD TRANSFUSION, AUTOLOGOUS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE TRANSPLANTATION; CLEFT PALATE; DOGS; DRUG CARRIERS; GROWTH SUBSTANCES; HUMANS; ILIUM; MAXILLA; POLYGLACTIN 910; PROTEINS; RECOMBINANT PROTEINS; TIME FACTORS; WOUND HEALING;

EID: 0029891982     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199608000-00006     Document Type: Article

References (70)

1. Gorlin, R. J., Cohen, M. M., and Levin, L. S. Orofacial Clefting Syndromes: General Aspects. In R. L. Gorlin (Ed.), Syndromes of the Head and Neck. New York: Oxford University Press, 1990. P. 698.
2. Vanderas, A. P. Incidence of cleft lip, cleft palate, and cleft lip and palate among races: A review. Cleft Palate J. 24: 216, 1987.
3. Jones, M. C. Facial clefting: Etiology and development pathogenesis. Clin. Plast. Surg. 20: 599, 1993.
4. Mayer, M. H. Clinical Perspectives on Bone Grafting: Avoiding the Complications of Developmental Malformations. In A. E. Seyfer and J. O. Hollinger (Eds.), Bone Repair and Regeneration. Philadelphia: Saunders, 1994. P. 365.
5. Dado, D. V. Primary (early) alveolar bone grafting. Clin. Plast. Surg. 20: 683, 1993.
6. Kortebein, M. J., Nelson, C. L., and Sadove, A. M. Retrospective analysis of 135 secondary alveolar cleft grafts using iliac or calvarial bone. J. Oral Maxillofac. Surg. 49: 493, 1991.
7. Centers for Disease Control. Transmission of HIV through bone transplantation: Case report and public health recommendations. M.M.W.R. 37: 481, 1988.
8. Centers for Disease Control. Update: Mortality attributable to HIV infection/AIDS among persons aged 25-44 years - United States, 1990 and 1991. M.M.W.R. 42: 481, 1993.
9. Buck, B. E., Malinin, T. I., and Brown, M. D. Bone transplantation and human immunodeficiency virus: An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin. Orthop. 240: 129, 1989.
10. Buck, B. E., Resnick, L., and Shah, S. M. Human immunodeficiency virus cultured from bone: Implications for transplantation. Clin. Orthop. 251: 249, 1990.
11. Wozney, J. M. The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 32: 160, 1992.
12. Kingsley, D. M. What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends in Genetics 10: 16, 1994.
13. Kingsley, D. M. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8: 133, 1994.
14. Reddi, A. H. Bone Induction: Introduction and Perspectives. In A. Veis (Ed.), The Chemistry and Biology of Mineralized Connective Tissues. Amsterdam: Elsevier-North Holland, 1981. P. 593.
15. Urist, M. Bone Morphogenetic Protein, Bone Regeneration, Heterotopic Ossification and the Bone-Bone Marrow Consortium. In W. A. Peck (Ed.), Bone and Mineral Research. New York: Elsevier Science Publishers, 1989. P. 57.
16. Wozney, J. M., Rosen, V., Celeste, A. J., et al. Novel regulators of bone formation: Molecular clones and activities. Science 242: 1528, 1988.
17. Luyten, F. P., Cunningham, N. S., Ma, S., et al. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J. Biol. Chem. 264: 13377, 1989.
18. Celeste, A. J., Iannazzi, J. A., Taylor, R. C., et al. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. U.S.A. 87: 9843, 1990.
19. Özkaynak, E., Rueger, D. C., Drier, E. A., et al. OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J. 9: 2085, 1990.
20. Sampath, K. T., Coughlin, J. E., Whetstone, R. M., et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-β superfamily. J Biol. Chem., 265: 13198, 1990.
21. Celeste, A. J., Taylor, R., Yamaji, N., et al. Molecular cloning of BMP-8: A protein present in bovine bone which is highly related to BMP-5/6/7 subfamily of osteoinductive molecules (Abstract). J. Cell. Biochem. 16F: 100, 1992.
22. Özkaynak, E., Schnegelsberg, P. N. J., Jin, D. F., et al. Osteogenic protein-2: A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J. Biol. Chem. 267: 25220, 1992.
23. Rosen, V., and Thies, R. S. The BMP proteins in bone formation and repair. Trends Genet. 8: 97, 1992.
24. Wang, E. A., Rosen, V., D'Alessandro, J. S., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. U.S.A. 87: 2220, 1990.
25. Toriumi, D. M., Kotler, H. S., Luxenberg, D. P., et al. Mandibular reconstruction with a recombinant bone-inducing factor: Functional, histologie, and biomechanical evaluation. Arch. Otolaryngol. Head Neck Surg. 117: 1101, 1991.
26. Yasko, A. W., Lane, J. M., Fellinger, E. J., et al. The healing of segmental bone defects induced by recombinant human bone morphogenetic protein (rhBMP-2). J. Bone Joint Surg. 74A: 659, 1992.
27. Kenley, R. A., Yim, K., Abrams, J., et al. Biotechnology and bone graft substitutes. Pharmacol. Res. 10: 1393, 1993.
28. Kenley, R., Marden, L., Turek, T., et al. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J. Biomed. Mater. Res. 28: 1139, 1994.
29. Marden, L. J., Hollinger, J. O., Chaudhari, A., et al. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J. Biomed. Mater. Res. 28: 1127, 1994.
30. Hollinger, J. O. Factors for osseous repair and delivery, part 1. J. Craniofac. Surg. 4: 115, 1993.
31. Hollinger, J. O. Factors for osseous repair and delivery, part 2. J. Craniofac. Surg. 4: 135, 1993.
32. Ron, E., Schaub, R. G., and Turek, T. Formulations of blood-clot polymer matrix for delivery of osteogenic proteins. U.S. Patent No. 5,171,579, 1992.
33. Wozney, J. M. Bone morphogenetic proteins. Prog. Growth Factors 1: 267, 1989.
34. Hollinger, J. O., Schmitz, J. P., Mark, D. E., and Seyfer, A. E. Osseous wound healing with xenogeneic bone implants with a biodegradable carrier. Surgery 107: 50, 1990.
35. Hollinger, J. O., and Schmitz, J. P. Restoration of bone discontinuities in dogs using a biodegradable implant. J. Oral Maxillofac. Surg. 45: 594, 1987.
36. Hollinger, J. O., and Kleinschmidt, J. The critical size defect as an experimental model to test bone repair materials. J. Craniofac. Surg. 1: 60, 1990.
37. Marx, R. E., Miller, R. I., Ehler, W. J., et al. A comparison of particulate allogeneic and particulate autogenous bone grafts into maxillary alveolar clefts in dogs. J. Oral Maxillofac. Surg. 42: 3, 1984.
38. Boyne, P. J. Use of marrow-cancellous bone grafts in maxillary alveolar and palatal clefts. J. Dent. Res. 53: 821, 1974.
39. Bradley, P. F., and Kincaid, L. C. The use of the rhesus monkey in research in alveolar surgery. Br. J. Oral Surg. 12: 70, 1974.
40. El Deeb, M., Horswell, B., and Waite, D. E. A primate model for producing experimental alveolar cleft defects. J. Oral Maxillofac. Surg. 43: 523, 1985.
41. Schachar, N. S., Henry, W. B., Jr., Wadsworth, P. L., et al. Immune Response to Massive Osteoarticular Allografts in a Feline Model. In G. Friedlaender (Ed.), Osteochondral Allografts: Biology, Banking, and Clinical Applications. Boston: Little, Brown, 1981.
42. Tomford, W. W., Starkweather, R. J., and Goldman, M. H. A study of the clinical incidence of infection in the use of banked allograft bone. J. Bone Joint Surg. 63A: 244, 1981.
43. Henricson, A., Hulth, A., and Johnell, O. The occurrence of accessory immunologic cells in bone induction. Clin. Orthop. 264: 270, 1991.
44. Asselmeier, M. A., Caspari, R. B., and Bottenfield, S. A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus. Am. J. Sports Med. 21: 170, 1993.
45. Nemzek, J. A., Arnoczky, S. P., and Swenson, C. L. Retroviral transmission by the transplantation of connective-tissue allografts. J. Bone Joint Surg. 76A: 1036, 1994.
46. Urist, M. R. Bone: Formation by autoinduction. Science 150: 893, 1965.
47. Urist, M. R., Silverman, B. F., Buring, K., et al. The bone induction principle. Clin. Orthop. 53: 243, 1967.
48. Urist, M. R., and Strates, B. S. Bone morphogenetic protein. J. Dent. Res. 50: 1392, 1971.
49. Gerhart, T. N., Kirker-Head, C. A., Kriz, M. J., et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein (rhBMP-2). Trans. Orthop. Res. Soc. 16: 172, 1991.
50. Zegzula, H. D., Hollinger, J. O., Buck. D. C., et al. Bone regeneration using recombinant human bone morphogenetic protein-2. (Submitted for publication.)
51. Hollinger, J. O., Zegzula, D., Buck, D., et al. Reconstruction and regeneration of critical-sized segmental defects in radii of rhesus nonhuman primates. In preparation.
52. Ellingsworth, L. R., DeLustro, F., Brennan, J. E., et al. The human immune response to reconstituted bovine collagen. J. Immunol. 136: 877, 1986.
53. DeLustro, F., Dasch, J., Keefe, J., and Ellingsworth, L. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin. Orthop. 260: 263, 1990.
54. van Luyn, M. J. A., van Wachem, P. B., Olde Damink, L. H. H., et al. Secondary cytotoxicity of cross-linked dermal sheep collagens during repeated exposure to human fibroblasts. Biomaterials 13: 1017, 1992.
55. Chu, C. C. The Degradation and Biocompatibility of Suture Materials. In D. F. Williams (Ed.), CRC Critical Reviews in Biocompatibility, Boca Raton, Fla.: CRC Press, 1985. P. 261.
56. Hollinger, J. O., and Battistone, G. C. Biodegradable bone repair materials: Synthetic polymers and ceramics. Clin. Orthop. 207: 290, 1986.
57. Bostman, O. M. Absorbable implants for the fixation of fractures. J. Bone Joint Surg. 73A: 148, 1991.
58. Bostman, O. M., Hirvensalo, E., Makinen, J., and Rokkanen, P. Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. J. Bone Joint Surg. 72B: 592, 1990.
59. Bostman, O. M. Absorbable implants for fixation of fractures. J. Bone Joint Surg. 73A: 148, 1991.
60. Bostman, O. M., Paivarinta, U., Partio, E., et al. Absorbable polyglycolide screws in internal fixation of femoral osteotomies in rabbits. Acta Orthop. Scand. 62: 587, 1991.
61. Bergsma, E. J., Rozema, F. R., Bos, R. R. M., and De Bruijn, W. C. Foreign body reactions to resorbable poly(L-lactide) bone plates and screws used for fixation of unstable zygomatic fractures. J. Oral Maxillofac. Surg. 51: 666, 1993.
62. Li, S., Garreua, H., and Vert, M. Structure-property relationships in the case of the degradation of massive aliphatic poly(a-hydroxy-acids) in aqueous media: 1. Poly(DL-lactic acid). J. Mater. Sci. Mater. Med. 1: 123, 1990.
63. Li, S., Garreua, H., and Vert, M. Structure-property relationships in the case of the degradation of massive aliphatic poly(a-hydroxy-acids) in aqueous media: 2. Degradation of lactide-glycolide PLA37.5:GA25 and PLA75:GA25 poly(DL-lactic acid). J. Mater. Sci. Mater. Med. 1: 131, 1990.
64. Li, S., Garreua, H., and Vert, M. Structure-property relationships in the case of the degradation of massive aliphatic poly(a-hydroxy-acids) in aqueous media: 3. Influence of the morphology of poly(L-lactic acid). J. Mater. Sci. Mater. Med. 1: 198, 1990.
65. Nakamura, T., Shimizo, Y., Okumura, N., et al. Tumorigenicity of poly-L-lactide (PLLA) plates compared with medical-grade polyethylene. J. Biomed. Mater. Res. 28: 17, 1994.
66. Bos, R. M., Rozema, F. R., Boering, G., et al. Degradation of and tissue reaction to biodegradable poly (L-lactide) for use as internal fixation for fractures: A study in rats. Biomaterials 12: 32, 1991.
67. Campbell, J. P., Edsberg, L., and Meyer, A. E. Polylactide inhibition of carcinoma cell growth in vitro. J. Oral Maxillofac. Surg. 52: 49, 1994.
68. Assoian, R. K., and Sporn, M. B. Type β transforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102: 1217, 1986.
69. Hart, C. E., and Bowen-Pope, D. F. Platelet-derived growth factor receptor: Current views of the two-subunit model. J. Invest. Dermatol. 94: 53, 1990.
70. Vlodavsky, I., Bar-Shavit, R., Ishai-Michaeli, R., et al. Extracellular sequestration and release of fibroblast growth factor: A regulatory mechanism? Trends in Biochemical Sciences 16: 268, 1991.